170 related articles for article (PubMed ID: 9119091)
1. Prelabour rupture of membranes at term: early induction of labour versus expectant management.
Alcalay M; Hourvitz A; Reichman B; Luski A; Quint J; Barkai G; Mashiach S; Lipitz S
Eur J Obstet Gynecol Reprod Biol; 1996 Dec; 70(2):129-33. PubMed ID: 9119091
[TBL] [Abstract][Full Text] [Related]
2. Prelabour rupture of the membranes at term--no advantage of delaying induction for 24 hours.
Akyol D; Mungan T; Unsal A; Yüksel K
Aust N Z J Obstet Gynaecol; 1999 Aug; 39(3):291-5. PubMed ID: 10554936
[TBL] [Abstract][Full Text] [Related]
3. A randomised trial of two expectant managements of prelabour rupture of the membranes at 34 to 42 weeks.
Ladfors L; Mattsson LA; Eriksson M; Fall O
Br J Obstet Gynaecol; 1996 Aug; 103(8):755-62. PubMed ID: 8760703
[TBL] [Abstract][Full Text] [Related]
4. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).
Dare MR; Middleton P; Crowther CA; Flenady VJ; Varatharaju B
Cochrane Database Syst Rev; 2006 Jan; (1):CD005302. PubMed ID: 16437525
[TBL] [Abstract][Full Text] [Related]
5. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group.
Hannah ME; Ohlsson A; Farine D; Hewson SA; Hodnett ED; Myhr TL; Wang EE; Weston JA; Willan AR
N Engl J Med; 1996 Apr; 334(16):1005-10. PubMed ID: 8598837
[TBL] [Abstract][Full Text] [Related]
6. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL-trial).
van der Ham DP; Nijhuis JG; Mol BW; van Beek JJ; Opmeer BC; Bijlenga D; Groenewout M; Arabin B; Bloemenkamp KW; van Wijngaarden WJ; Wouters MG; Pernet PJ; Porath MM; Molkenboer JF; Derks JB; Kars MM; Scheepers HC; Weinans MJ; Woiski MD; Wildschut HI; Willekes C
BMC Pregnancy Childbirth; 2007 Jul; 7():11. PubMed ID: 17617892
[TBL] [Abstract][Full Text] [Related]
7. EFFECTIVENESS AND SAFETY OF 2-HOURLY 20 MCG ORAL MISOPROSTOL SOLUTION COMPARED TO STANDARD INTRAVENOUS OXYTOCIN IN LABOUR INDUCTION DUE TO PRE-LABOUR RUPTURE OF MEMBRANES AT TERM: A RANDOMISED CLINICAL TRIAL AT KENYATTA NATIONAL HOSPITAL.
Mbaluka CM; Kamau K; Karanja JG; Mugo N
East Afr Med J; 2014 Sep; 91(9):303-10. PubMed ID: 26866082
[TBL] [Abstract][Full Text] [Related]
8. WITHDRAWN: Oxytocin for prelabour rupture of membranes at or near term.
Tan BP; Hannah ME
Cochrane Database Syst Rev; 2007 Jul; (2):CD000157. PubMed ID: 17636608
[TBL] [Abstract][Full Text] [Related]
9. Management of term pregnancy with premature rupture of the membranes and unfavourable cervix.
van der Walt D; Venter PF
S Afr Med J; 1989 Jan; 75(2):54-6. PubMed ID: 2913680
[TBL] [Abstract][Full Text] [Related]
10. Premature rupture of membranes at term with an unfavorable cervix: comparison of expectant management, vaginal prostaglandin, and oxytocin induction.
McCaul JF; Rogers LW; Perry KG; Martin RW; Allbert JR; Morrison JC
South Med J; 1997 Dec; 90(12):1229-33. PubMed ID: 9404911
[TBL] [Abstract][Full Text] [Related]
11. Management of prelabour rupture of the membranes in term primigravidae: report of a randomized prospective trial.
Grant JM; Serle E; Mahmood T; Sarmandal P; Conway DI
Br J Obstet Gynaecol; 1992 Jul; 99(7):557-62. PubMed ID: 1525095
[TBL] [Abstract][Full Text] [Related]
12. Controlled comparison of induction versus expectant care for prelabor rupture of the membranes at term.
Ottervanger HP; Keirse MJ; Smit W; Holm JP
J Perinat Med; 1996; 24(3):237-42. PubMed ID: 8827572
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin gel versus oxytocin - prelabour rupture of membranes at term - A randomised controlled trial.
Mahomed K; Wild K; Weekes CR
Aust N Z J Obstet Gynaecol; 2018 Dec; 58(6):654-659. PubMed ID: 29468633
[TBL] [Abstract][Full Text] [Related]
14. Oxytocin for prelabour rupture of membranes at or near term.
Tan BP; Hannah ME
Cochrane Database Syst Rev; 2000; 1997(2):CD000157. PubMed ID: 10796159
[TBL] [Abstract][Full Text] [Related]
15. Expectant management of rupture of membranes at term.
Morales WJ; Lazar AJ
South Med J; 1986 Aug; 79(8):955-8. PubMed ID: 3526572
[TBL] [Abstract][Full Text] [Related]
16. Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial.
Mercer BM; Crocker LG; Boe NM; Sibai BM
Am J Obstet Gynecol; 1993 Oct; 169(4):775-82. PubMed ID: 8238131
[TBL] [Abstract][Full Text] [Related]
17. Dinoprostone vaginal slow-release system (Propess) compared to expectant management in the active treatment of premature rupture of the membranes at term: impact on maternal and fetal outcomes.
Larrañaga-Azcárate C; Campo-Molina G; Pérez-Rodríguez AF; Ezcurdia-Gurpegui M
Acta Obstet Gynecol Scand; 2008; 87(2):195-200. PubMed ID: 18231888
[TBL] [Abstract][Full Text] [Related]
18. Misoprostol versus expectant management in premature rupture of membranes at term.
da Graça Krupa F; Cecatti JG; de Castro Surita FG; Milanez HM; Parpinelli MA
BJOG; 2005 Sep; 112(9):1284-90. PubMed ID: 16101609
[TBL] [Abstract][Full Text] [Related]
19. Optimal timing of labor induction after prelabor rupture of membranes at term: a secondary analysis of the TERMPROM study.
Melamed N; Berghella V; Ananth CV; Lipworth H; Yoon EW; Barrett J
Am J Obstet Gynecol; 2023 Mar; 228(3):326.e1-326.e13. PubMed ID: 36116523
[TBL] [Abstract][Full Text] [Related]
20. Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes.
Ngai SW; Chan YM; Lam SW; Lao TT
BJOG; 2000 Feb; 107(2):222-7. PubMed ID: 10688506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
